Follow us on social media!
Upcoming Programs
Annual Events
Pharmacy Flash
AzPA Pharmacy Flash
- FDA approves Cobenfy for adults with schizophrenia November 19, 2024Bristol Myers Squibb's Cobenfy, a first-in-class muscarinic agonist, has been approved for the treatment of schizophrenia in adults, based on the EMERGENT clinical trials. The medication selectively targets M1 and M4 brain receptors without blocking D2 receptors.
- Active feedback improves pharmacist participation in heart failure treatment November 19, 2024A study presented at the American Heart Association's Scientific Sessions 2024 found that pharmacists who received active feedback about their heart failure patients increased patient interactions and prescribed more medication adjustments.
- PTC wins FDA approval for first brain-delivered gene therapy Kebilidi November 19, 2024PTC Therapeutics' Kebilidi, the first U.S. gene therapy administered directly in the brain, has received FDA approval to treat the rare AADC deficiency. The minimally invasive procedure boosts the AADC enzyme and restores dopamine production.
Member Newsletter
AzPA sends out a bi-monthly member newsletter containing pertinent Arizona pharmacy news, industry updates, information on events and programs, and more!
AzPA Podcast Network
AzPA presents an innovative podcast intended for pharmacists and pharmacy technicians to obtain continuing education credit. The podcast also provides current health information and hot topics in the evolving world of pharmacy.
Career Center
Looking for a new career? Check out the career center for job postings or post your resume!